Medications and Injections: Weighing Risks and Benefits
At a Glance
For osteoarthritis pain, treatment should match your health risks and goals. Anti-inflammatory creams may limit whole-body exposure, while pills and injections can affect the stomach, heart, kidneys, blood sugar, or surgery timing; PRP and stem cells are not routinely recommended.
When lifestyle changes like exercise and weight management aren’t enough to manage osteoarthritis (OA) pain, medications and injections can provide additional relief. However, these treatments are not “one size fits all.” Current medical guidelines emphasize a shared decision-making approach, where you and your doctor weigh the potential benefits against your personal health risks, particularly your kidney, heart, and stomach health [1][2].
Topical and Oral Medications
- Topical NSAIDs: Creams or gels containing non-steroidal anti-inflammatory drugs (like diclofenac) are strongly recommended for knee OA and recommended for hand OA [1][2]. Because they are applied directly to the skin, they provide relief with significantly lower “systemic exposure” than pills. However, absorption and adverse effects are not zero—they can cause skin reactions, and you should not combine them with oral NSAIDs without a doctor’s advice. They are also less effective for deep joints like the hip [3][4].
- Oral NSAIDs: Pills like ibuprofen or naproxen are effective but carry more significant risks. They should be used at the lowest effective dose for the shortest time possible [5]. Your doctor must carefully evaluate interactions with other medicines (like anticoagulants, ACE inhibitors, or diuretics) and your risk for:
- Gastrointestinal (GI) Issues: Risk of stomach ulcers or bleeding. For those at higher risk, a proton-pump inhibitor (PPI) is sometimes selectively prescribed alongside an NSAID to protect the stomach [6][7].
- Cardiovascular Risks: Oral NSAIDs can raise blood pressure and increase the risk of heart events [4][6].
- Kidney Health: NSAIDs can decrease blood flow to the kidneys, which is a particular danger for people who are dehydrated, older adults, or those with chronic kidney disease (CKD) [4].
- Acetaminophen: Once considered the first-line treatment, its average benefit for OA is often quite small, and guidelines frequently offer only conditional recommendations [1][2]. Explicit warnings apply: avoid exceeding the maximum daily dose, do not mix with alcohol, use caution with liver disease, and be very careful not to accidentally “stack” it with other over-the-counter cold/flu medications that also contain acetaminophen.
- Duloxetine: Originally developed for depression, this is sometimes conditionally recommended for OA because it helps change how the nervous system processes pain [1][5]. Common adverse effects include nausea and fatigue, and it has important interactions with other medications.
Joint Injections: Steroids and Beyond
Injections deliver medication directly into the joint environment. Important safety note: A joint that is acutely hot, red, or suspected to be infected must be assessed by a doctor before any injection is given.
- Corticosteroids: “Steroid shots” can provide significant short-term pain relief (often lasting a few weeks to a few months) [8][9]. There is no universally safe maximum number of injections; repeated injections at short intervals have raised concerns about accelerated cartilage loss [10]. Injections can also cause transient spikes in blood sugar (hyperglycemia), which is critical if you have diabetes.
- Hyaluronic Acid (HA): Often called “gel shots.” Evidence for HA is mixed; while some patients find relief, many major guidelines do not strongly recommend it because the benefit over a placebo is often inconsistent [13][14].
- Platelet-Rich Plasma (PRP) and Stem Cells: These “regenerative” treatments are not recommended by major guidelines like ACR or OARSI for routine OA care [15][16]. Current research has not proven that they regrow cartilage, and they are typically expensive out-of-pocket costs [17][18].
A Note on Opioids
Current guidelines strongly advise against routine opioid use (like oxycodone) for long-term OA management [2]. Medications like tramadol may be considered in selected patients when other treatments are ineffective or contraindicated [1]. However, any opioid use requires careful discussion of interactions, risks of dependence and respiratory depression, a plan for short duration, and a safe tapering strategy [19].
Common questions in this guide
Are topical NSAIDs safer than oral NSAIDs for osteoarthritis?
What are the main risks of oral NSAIDs for osteoarthritis?
How much relief do steroid injections provide, and how often can I receive them?
How long should I wait after a steroid injection before joint replacement?
Do PRP or stem cell injections regrow cartilage in osteoarthritis?
Is acetaminophen effective for osteoarthritis pain?
Are opioids recommended for long-term osteoarthritis pain?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on osteoarthritis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my medical history (heart, stomach, or kidney health), is an oral NSAID safe for me, or should we start with a topical version?
- 2.If I take an oral NSAID, do I need to take a second medication to protect my stomach from ulcers?
- 3.How frequently can I safely receive steroid injections based on your clinic's protocols and my diabetes risk?
- 4.If I am considering a joint replacement in the near future, how long must I wait after my last injection before having surgery?
- 5.Why do major guidelines recommend against treatments like PRP or stem cells despite their popularity in the media?
References
References (19)
- 1
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.
Kolasinski SL, Neogi T, Hochberg MC, et al.
Arthritis care & research 2020; (72(2)):149-162 doi:10.1002/acr.24131.
PMID: 31908149 - 2
OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.
Bannuru RR, Osani MC, Vaysbrot EE, et al.
Osteoarthritis and cartilage 2019; (27(11)):1578-1589 doi:10.1016/j.joca.2019.06.011.
PMID: 31278997 - 3
Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
Rannou F, Pelletier JP, Martel-Pelletier J
Seminars in arthritis and rheumatism 2016; (45(4 Suppl)):S18-21.
PMID: 26806189 - 4
Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
Cooper C, Chapurlat R, Al-Daghri N, et al.
Drugs & aging 2019; (36(Suppl 1)):15-24 doi:10.1007/s40266-019-00660-1.
PMID: 31073921 - 5
Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis.
da Costa BR, Pereira TV, Saadat P, et al.
BMJ (Clinical research ed.) 2021; (375()):n2321 doi:10.1136/bmj.n2321.
PMID: 34642179 - 6
Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.
Szeto CC, Sugano K, Wang JG, et al.
Gut 2020; (69(4)):617-629 doi:10.1136/gutjnl-2019-319300.
PMID: 31937550 - 7
Practice Advisory on the Appropriate Use of NSAIDs in Primary Care.
Ho KY, Cardosa MS, Chaiamnuay S, et al.
Journal of pain research 2020; (13()):1925-1939 doi:10.2147/JPR.S247781.
PMID: 32821151 - 8
Intra-articular corticosteroid injections provide a clinically relevant benefit compared to placebo only at short-term follow-up in patients with knee osteoarthritis: A systematic review and meta-analysis.
Bensa A, Albanese J, Boffa A, et al.
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2024; (32(2)):311-322 doi:10.1002/ksa.12057.
PMID: 38294103 - 9
Efficacy of Intra-Articular Corticosteroid Injection for Nonsurgical Management of Trapeziometacarpal Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Krez AN, Wu KA, Klifto KM, et al.
The Journal of hand surgery 2024; (49(6)):511-525 doi:10.1016/j.jhsa.2024.02.001.
PMID: 38530683 - 10
The Use of Steroid Injections for Hand and Wrist Pathologies.
Bell RJ, Cervenak R, Flint MI, et al.
Cureus 2025; (17(11)):e97104 doi:10.7759/cureus.97104.
PMID: 41416321 - 11
Association of intra-articular injection and knee arthroscopy prior to primary knee replacement with the timing and outcomes of surgery: Retrospective cohort study using data from the Clinical Practice Research Datalink GOLD database.
Strang M, Broomfield J, Whitehouse M, et al.
PloS one 2024; (19(11)):e0311947 doi:10.1371/journal.pone.0311947.
PMID: 39570872 - 12
Intra-articular steroid injections in large joint arthritis: A survey of current practice.
Yaghmour KM, Loumpardias GA, Elbahi A, et al.
Musculoskeletal care 2022; (20(2)):349-353 doi:10.1002/msc.1596.
PMID: 34694056 - 13
Nonoperative Treatments for Knee Osteoarthritis: An Evaluation of Treatment Characteristics and the Intra-Articular Placebo Effect: A Systematic Review.
Vannabouathong C, Bhandari M, Bedi A, et al.
JBJS reviews 2018; (6(7)):e5 doi:10.2106/JBJS.RVW.17.00167.
PMID: 30020117 - 14
Efficacy of intra-articular platelet-rich plasma compared with placebo in knee osteoarthritis: A systematic review and meta-analysis.
Auroux M, Debionne T, Mainbourg S, Chapurlat R
Joint bone spine 2025; (92(6)):105947 doi:10.1016/j.jbspin.2025.105947.
PMID: 40653151 - 15
Injectable therapies for knee osteoarthritis.
Ding JB, Hu K
Reumatologia 2021; (59(5)):330-339 doi:10.5114/reum.2021.110612.
PMID: 34819708 - 16
Should Platelet-Rich Plasma or Stem Cell Therapy Be Used to Treat Osteoarthritis?
Rashid H, Kwoh CK
Rheumatic diseases clinics of North America 2019; (45(3)):417-438 doi:10.1016/j.rdc.2019.04.010.
PMID: 31277753 - 17
Clinical and radiographic comparison of a single LP-PRP injection, a single hyaluronic acid injection and daily NSAID administration with a 52-week follow-up: a randomized controlled trial.
Buendía-López D, Medina-Quirós M, Fernández-Villacañas Marín MÁ
Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology 2018; (19(1)):3 doi:10.1186/s10195-018-0501-3.
PMID: 30128934 - 18
Comprehensive Review of Knee Osteoarthritis Pharmacological Treatment and the Latest Professional Societies' Guidelines.
Primorac D, Molnar V, Matišić V, et al.
Pharmaceuticals (Basel, Switzerland) 2021; (14(3)) doi:10.3390/ph14030205.
PMID: 33801304 - 19
Tramadol for osteoarthritis.
Toupin April K, Bisaillon J, Welch V, et al.
The Cochrane database of systematic reviews 2019; (5()):CD005522 doi:10.1002/14651858.CD005522.pub3.
PMID: 31132298
This page is for informational purposes only and does not constitute medical advice. Your clinician can help you weigh medication and injection choices against your medical history and treatment goals.